Details for Patent: 10,603,308
✉ Email this page to a colleague
Which drugs does patent 10,603,308 protect, and when does it expire?
Patent 10,603,308 protects ZTALMY and is included in one NDA.
This patent has twenty patent family members in eleven countries.
Summary for Patent: 10,603,308
Title: | Methods and compositions for treatment of epileptic disorders |
Abstract: | Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof. |
Inventor(s): | During; Matthew (Weston, CT) |
Assignee: | OVID THERAPEUTICS INC. (New York, NY) |
Application Number: | 16/447,300 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,603,308
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF SEIZURES ASSOCIATED WITH CYCLIN-DEPENDENT KINASE-LIKE 5 (CDKL5) DEFICIENCY DISORDER (CDD) IN PATIENTS 2 YEARS OF AGE AND OLDER | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,603,308
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2017311412 | ⤷ Try a Trial | |||
Australia | 2023216824 | ⤷ Try a Trial | |||
Brazil | 112019002538 | ⤷ Try a Trial | |||
Canada | 3032686 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |